文献速递慢性静脉疾病

血管外科学会血管质量倡议:静脉曲张治疗的当代基准数据

Society for Vascular Surgery Vascular Quality Initiatives contemporary benchmarks: Varicose vein treatments.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2026-09-17

基于血管质量倡议静脉曲张注册数据库2014至2025年数据,分析44,883例患者共71,889次手术,其中38,978例(86.8%)以消融为主要术式。热消融比例从91.5%降至53.0%,非热消融从0%升至30.9%。在23,598例初次主干静脉消融患者中,热消融在VCSS和HASTI改善方面均优于非热消融,但全身并发症更少,局部并发症相似。

要点

  • 热消融比例下降而非热消融上升,趋势具有统计学意义。
  • 热消融的VCSS和HASTI平均改善幅度及改善患者比例均更高。
  • 热消融全身并发症发生率低于非热消融,局部并发症无差异。

核心结论

  • 静脉消融可使多数患者的静脉功能不全症状得到改善,无论采用何种消融方式,并发症均轻微且不常见。

研究设计与样本

  • 回顾性队列研究,查询血管质量倡议静脉曲张注册数据库2014至2025年数据。
  • 共纳入44,883例患者、71,889次手术,其中38,978例(86.8%)以消融为主要术式。
  • 排除后分析23,598例初次主干静脉消融患者,包括21,920例(92.9%)热消融和1,678例(7.1%)非热消融。

主要发现

  • 热消融比例从91.5%降至53.0%(P < .001),非热消融从0%升至30.9%(P < .001),高位结扎剥脱术从0%升至2.3%(P < .001)但仍较低。
  • 热消融组全身并发症发生率为0.3%,非热消融组为0.7%(P = .007),局部并发症率两组相似。
  • 热消融组VCSS平均改善-4.3,非热消融组-3.2(P < .001);HASTI平均改善-6.9 vs -3.8(P < .001)。
  • 热消融组VCSS改善患者比例为83.9%,非热消融组为74.6%(P < .001);HASTI改善比例分别为86.3%和71.3%(P < .001)。

临床怎么用

  • 选择消融方式时可参考基准数据:热消融在症状评分改善上更优且全身并发症更少,非热消融可用于特定患者人群。
  • 非热消融患者更多为男性、基线溃疡比例更高但HASTI评分更低,且更少接受同期手术。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Venous ablation is the main procedural treatment of patients with varicose veins. This study provides benchmark outcomes and utilization trends for thermal and nonthermal ablations for patients with varicose veins undergoing initial treatment in the Vascular Quality Initiative registry. METHODS: The Vascular Quality Initiative Varicose Veins Registry was queried for patients treated between 2014 and 2025 at a truncal vein with no previous varicose venous treatment. Patients were stratified by index intervention into thermal or nonthermal ablation groups. Primary outcomes included improvement in Venous Clinical Severity Score (VCSS) and patient-reported outcomes assessed by Heaviness, Achiness, Swelling, Throbbing, and Itching (HASTI). RESULTS: Among 44,883 patients undergoing 71,889 procedures, 38,978 (86.8%) were treated with ablation as the primary procedure. Thermal ablation declined from 91.5% to 53.0% of procedures (P < .001), whereas nonthermal ablation increased from 0% to 30.9% (P < .001) over the duration of the study. Ligation and stripping increased in the registry but remained low (0%-2.3%; P < .001). After exclusions, 23,598 patients undergoing initial truncal vein ablation were analyzed, including 21,920 (92.9%) thermal and 1678 (7.1%) nonthermal ablation. Patients undergoing thermal ablation were younger, had lower body mass index, had fewer previous deep vein thrombosis, were less likely to receive pre-/perioperative anticoagulation, and more often had deep venous reflux. Patients treated with nonthermal ablations were more likely to be male and had more baseline ulceration but lower baseline HASTI scores, underwent fewer concomitant procedures, and more frequently underwent treatment of truncal veins other than the great saphenous vein. Thermal ablation had fewer systemic complications (0.3% vs 0.7%; P = .007), whereas local complication rates were similar between groups. Thermal ablation produced greater mean improvements in VCSS (-4.3 vs -3.2; P < .001) and HASTI (-6.9 vs -3.8; P < .001) post-treatment. In addition, a higher proportion of patients treated with thermal ablation reported improvement in VCSS (83.9% vs 74.6%; P < .001) and HASTI (86.3% vs 71.3%; P < .001). CONCLUSIONS: Venous ablations improve symptoms of venous insufficiency in the majority of patients treated as measured by clinical severity scores and patient-reported outcomes. Complications are minor and infrequent regardless of the ablation modality.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Ochoa Chaar CI, Wells N, Ellis JL, et al. Society for Vascular Surgery Vascular Quality Initiatives contemporary benchmarks: Varicose vein treatments. J Vasc Surg Venous Lymphat Disord. 2026. PMID: 42753971. doi:10.1016/j.jvsv.2026.102619

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。